Lv4
760 积分 2025-04-23 加入
Avidity in antibody effector functions and biotherapeutic drug design
2个月前
已完结
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models
3个月前
已完结
Efficacy and safety profile of avelumab monotherapy
5个月前
已完结
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus
8个月前
已完结
Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies
8个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
8个月前
已完结
皖公网安备34019202002308
